Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID
· Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT
Ovid Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.65M | 548K | 566K | 631.56K | 567.53K | 473.53K | 391.53K | 296.25K | 198.38K | 123.38K | 1.5M | -414.89M | -414.9M | -414.9M | -207.97M | 214.09M | 221M | 221M |
Cost of Revenue | 268K | 317K | 453K | 854.39K | 1.09M | 1.33M | 1.6M | 1.64M | 1.65M | 1.69M | 1.3M | 913.21K | 549.84K | 161.87K | 161.87K | 105K | 53K | n/a |
Gross Profit | 6.55M | 548K | 566K | 631.56K | 165.07K | 75M | 74.52M | 73.98M | 73.87M | -1.57M | 206K | -415.81M | -415.45M | -415.07M | -208.13M | 213.98M | 220.95M | 221M |
Operating Income | -41.57M | -57.02M | -61.88M | -69.35M | -68.15M | -61.81M | -59.28M | -53.27M | -54.04M | -54.17M | -55.55M | -69.73M | -68.61M | -68.62M | 124.21M | 128.97M | 124.25M | 115.42M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 590.49K |
Pretax Income | -38.18M | -24.97M | -26.43M | -32.5M | -29.75M | -50.68M | -52.34M | -48.52M | -49.24M | -51.42M | -54.12M | -68.96M | -68.67M | -68.4M | 124.16M | 128.48M | 123.74M | 115.5M |
Net Income | -38.18M | -24.97M | -26.43M | -32.5M | -29.75M | -50.68M | -52.34M | -48.47M | -48.35M | -50.53M | -53.28M | -67.83M | -68.08M | -69.28M | 122.83M | 126.81M | 121.76M | 115M |
Selling & General & Admin | 21.32M | 24.54M | 25.69M | 28.5M | 29.77M | 29.91M | 31.09M | 30.07M | 30.9M | 30.91M | 32.44M | 34.03M | 33.16M | 31.54M | 37.23M | 39.38M | 40.06M | 40.54M |
Research & Development | 26.9M | 33.02M | 36.76M | 41.48M | 38.95M | 32.26M | 28.48M | 23.25M | 23.11M | 23.26M | 24.48M | 37.15M | 36.89M | 38.52M | 46.94M | 45.73M | 56.69M | 65.04M |
Other Expenses | 1K | 1K | 1K | -957 | -957 | 999.04K | 999.04K | 300K | 299.7K | -699.68K | -699.48K | 1.63K | 4.58K | 1.45K | -48.49K | -49.59K | -73.38K | -70.86K |
Operating Expenses | 48.22M | 57.56M | 62.45M | 69.98M | 68.72M | 62.28M | 59.67M | 53.56M | 53.82M | 53.44M | 56.19M | 70.33M | 69.61M | 70.06M | 84.17M | 85.11M | 96.75M | 105.58M |
Interest Expense | n/a | n/a | n/a | 1.54B | 1.54B | 1.54B | 1.54B | n/a | n/a | 284.13K | 284.13K | 284.13K | 284.13K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 48.22M | 57.56M | 62.45M | 69.98M | 68.72M | 62.28M | 59.67M | 53.56M | 54.24M | 54.3M | 57.05M | 71.18M | 70.05M | 70.06M | 84.17M | 85.11M | 96.75M | 105.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | -886K | -886K | -836K | -1.14M | -595K | 878K | 1.33M | 1.68M | 1.97M | 500.02K |
Shares Outstanding (Basic) | 1.25M | 71.05M | 71.01M | 70.98M | 70.92M | 70.72M | 70.69M | 70.62M | 70.53M | 70.3M | 70.47M | 70.4M | 69.47M | 70.03M | 67.51M | 66.97M | 67.82M | 66.09M |
Shares Outstanding (Diluted) | 71.11M | 71.05M | 71.01M | 70.98M | 71.2M | 70.72M | 70.69M | 70.62M | 70.53M | 70.49M | 70.47M | 70.43M | 70.39M | 70.35M | 68.16M | 67.93M | 67.82M | 66.58M |
EPS (Basic) | -0.54 | -0.35 | -0.38 | -0.47 | -0.43 | -0.73 | -0.75 | -0.69 | -0.69 | -0.72 | -0.76 | -0.98 | -0.99 | -1.01 | 1.77 | 1.80 | 1.69 | 1.51 |
EPS (Diluted) | -0.54 | -0.35 | -0.38 | -0.47 | -0.43 | -0.73 | -0.75 | -0.69 | -0.69 | -0.72 | -0.76 | -0.98 | -0.99 | -1.01 | 1.75 | 1.79 | 1.68 | 1.50 |
EBITDA | -41.3M | -56.6M | -61.47M | -65.63M | -64.45M | -58.26M | -55.47M | -52.28M | -52.79M | -52.76M | -54.46M | -69.03M | -68.27M | -68.38M | 124.45M | 129.24M | 124.54M | 115.73M |
EBIT | -41.38M | -57.22M | -62.08M | -66.48M | -65.29M | -57.94M | -55.42M | -52.27M | -53.04M | -54.17M | -55.55M | -69.73M | -68.61M | -68.61M | 124.21M | 128.97M | 124.25M | 115.42M |
Depreciation & Amortization | 569K | 618K | 613K | 854.39K | 831.39K | 567.39K | 829.39K | 867.95K | 1.14M | 1.35M | 1.03M | 644.34K | 280.98K | 235.68K | 236.61K | 262.78K | 289.69K | 314.7K |